Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice

Transforming Growth Factor β–induced Protein Promotes Severe Vascular Inflammatory Responses

(2014) Jong-Sup Bae et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa

(2014) Sae-Kwang Ku et al.   ARCHIVES OF PHARMACAL RESEARCH

Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo

(2014) Sae-Kwang Ku et al.   BMB Reports

Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo

(2014) Sae-Kwang Ku et al.   BMB Reports

Update in Sepsis 2012

(2013) James A. Russell et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Emodin-6-O-β-d-glucoside down-regulates endothelial protein C receptor shedding

(2013) Wonhwa Lee et al.   ARCHIVES OF PHARMACAL RESEARCH

Anticoagulant activities of piperlonguminine in vitro and in vivo

(2013) Wonhwa Lee et al.   BMB Reports

Inhibitory effects of epi-sesamin on HMGB1-induced vascular barrier disruptive responses in vitro and in vivo

(2013) Wonhwa Lee et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Gram-positive and gram-negative bacterial toxins in sepsis

(2013) Girish Ramachandran   Virulence

Role of high mobility group box 1 in inflammatory disease: Focus on sepsis

(2012) Jong-Sup Bae   ARCHIVES OF PHARMACAL RESEARCH

The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]

(2012) Jecko Thachil et al.   BRITISH JOURNAL OF HAEMATOLOGY

Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models

(2012) J.-S. BAE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models

(2012) Wonhwa Lee et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection

(2011) Ulf Andersson et al.   Annual Review of Immunology

Activated protein C inhibits high mobility group box 1 signaling in endothelial cells

(2011) J.-S. Bae et al.   BLOOD

Barrier protective effects of lycopene in human endothelial cells

(2011) Jae Woan Bae et al.   INFLAMMATION RESEARCH

HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption

(2010) Rachel K. Wolfson et al.   MICROVASCULAR RESEARCH

Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale

(2010) Beth A. Rose et al.   PHYSIOLOGICAL REVIEWS

Targeting HMGB1 in inflammation

(2009) Huan Yang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Sepsis as a model of SIRS

(2009) Madhav Bhatia   Frontiers in Bioscience-Landmark

HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products

(2009) Y.-H. Qin et al.   JOURNAL OF IMMUNOLOGY

Immunodesign of experimental sepsis by cecal ligation and puncture

(2009) Daniel Rittirsch et al.   Nature Protocols

Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways

(2008) Chengbo Sun et al.   BASIC RESEARCH IN CARDIOLOGY

Influences of dosage regimen and co-administration of low-molecular weight proteins and basic peptides on renal accumulation of arbekacin in mice

(2008) S. Murakami et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY